Stock Traders Purchase Large Volume of Call Options on AstraZeneca plc (AZN)
Shares of AstraZeneca plc (NYSE:AZN) were the recipient of unusually large options trading activity on Thursday. Stock investors bought 20,242 call options on the company, Analyst Ratings News reports. This is an increase of approximately 544% compared to the typical daily volume of 3,143 call options.
AZN has been the subject of a number of recent research reports. Analysts at Credit Suisse reiterated a “neutral” rating on shares of AstraZeneca plc in a research note on Thursday, August 14th. Separately, analysts at Barclays reiterated an “equal weight” rating on shares of AstraZeneca plc in a research note on Monday, August 4th. Finally, analysts at Berenberg Bank reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Thursday, July 31st. Four investment analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $57.00.
AstraZeneca plc (NYSE:AZN) traded up 3.08% on Thursday, hitting $73.19. 3,553,069 shares of the company’s stock traded hands. AstraZeneca plc has a 52 week low of $48.53 and a 52 week high of $82.68. The stock’s 50-day moving average is $72.85 and its 200-day moving average is $70.60. The company has a market cap of $92.439 billion and a P/E ratio of 44.29.
AstraZeneca plc (NYSE:AZN) last released its earnings data on Thursday, July 31st. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.21. The company had revenue of $6.45 billion for the quarter, compared to the consensus estimate of $6.24 billion. During the same quarter in the previous year, the company posted $1.20 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts predict that AstraZeneca plc will post $4.40 earnings per share for the current fiscal year.
The company also recently announced a semiannual dividend, which is scheduled for Monday, September 15th. Investors of record on Friday, August 15th will be paid a dividend of $0.90 per share. This represents a dividend yield of 2.48%. The ex-dividend date is Wednesday, August 13th.
AstraZeneca PLC (NYSE:AZN) is a global biopharmaceutical company.
Receive News & Ratings for AstraZeneca plc (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.